Ishaan Rischie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ishaan Rischie has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Sweta Sneha
Kennesaw State University, Marietta, GA, United States
6 shared publications - Rebecca Mbadiwe Awofisayo3 shared publications
- Valentina Nino
Kennesaw State University
3 shared publications - Hossain Shahriar
University of West Florida
2 shared publications - Lawrence Ignatius Kumah2 shared publications
- Srivarun Thalla
Kennesaw State University Kennesaw, GA United States
2 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Virtual Discharge in Healthcare: Enhancing Patient Safety and Efficiency with FMEAFMEA, hospital discharge, virtual nurse, patient safety (Preprint)
BACKGROUND Background: Hospital discharge is a critical yet often inefficient phase of patient care, prone to communication failures, incomplete patient education, and preventable readmissions. OBJECTIVE This study aimed to apply Failure Mode and Effects Analysis (FMEA) to compare in-person and virtual nurse discharge workflows at a 112-room county hospital that recorded 9,318 discharges in 2023 METHODS A mixed-methods approach combining structured observational analysis and focus groups with frontline nursing staff, and a comprehensive literature review. Swimlane flowcharts were used to map bedside nurse and virtual registered nurse workflows, and FMEA was applied to identify potential failure modes and assign Risk Priority Numbers based on severity, occurrence, and detectability. At the beginning of each focus group session, participants reported on the steps of the discharge process as they understood them and then provided information about failure modes that might occur at each step, consistent with established FMEA data collection methods. RESULTS Forty-five failure modes were identified across both workflows, comprising 20 in the in-person bedside nurse workflow and 25 in the virtual discharge workflow. The highest Risk Priority Number identified in the in-person workflow was 210, assigned to the failure mode of a nurse being interrupted during the After Visit Summary review. Virtual discharge workflows consistently produced lower Risk Priority Numbers: missed patient questions scored 150 in person versus 60 virtually, and failure to escalate concerns scored 120 in person versus 45 virtually. Virtual Registered Nurse workflows saved bedside nurses approximately 40 minutes per patient's discharge; target recommendations for each identified failure mode were developed. CONCLUSIONS FMEA provides an effective framework for identifying and mitigating discharge process failures. Virtual discharge workflows demonstrate superior safety profiles and efficiency compared to traditional in-person methods. Integrating Virtual Registered Nurses reduces bedside nursing workload, improves consistency in patient education, and supports workforce sustainability amid ongoing nursing shortages CLINICALTRIAL Not applicable
- 18 September 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessVirtual Discharge in Healthcare: Enhancing Patient Safety and Efficiency with FMEAFMEA, hospital discharge, virtual nurse, patient safety (Preprint)
BACKGROUND Background: Hospital discharge is a critical yet often inefficient phase of patient care, prone to communication failures, incomplete patient education, and preventable readmissions. OBJECTIVE This study aimed to apply Failure Mode and Effects Analysis (FMEA) to compare in-person and virtual nurse discharge workflows at a 112-room county hospital that recorded 9,318 discharges in 2023 METHODS A mixed-methods approach combining structured observational analysis and focus groups with frontline nursing staff, and a comprehensive literature review. Swimlane flowcharts were used to map bedside nurse and virtual registered nurse workflows, and FMEA was applied to identify potential failure modes and assign Risk Priority Numbers based on severity, occurrence, and detectability. At the beginning of each focus group session, participants reported on the steps of the discharge process as they understood them and then provided information about failure modes that might occur at each step, consistent with established FMEA data collection methods. RESULTS Forty-five failure modes were identified across both workflows, comprising 20 in the in-person bedside nurse workflow and 25 in the virtual discharge workflow. The highest Risk Priority Number identified in the in-person workflow was 210, assigned to the failure mode of a nurse being interrupted during the After Visit Summary review. Virtual discharge workflows consistently produced lower Risk Priority Numbers: missed patient questions scored 150 in person versus 60 virtually, and failure to escalate concerns scored 120 in person versus 45 virtually. Virtual Registered Nurse workflows saved bedside nurses approximately 40 minutes per patient's discharge; target recommendations for each identified failure mode were developed. CONCLUSIONS FMEA provides an effective framework for identifying and mitigating discharge process failures. Virtual discharge workflows demonstrate superior safety profiles and efficiency compared to traditional in-person methods. Integrating Virtual Registered Nurses reduces bedside nursing workload, improves consistency in patient education, and supports workforce sustainability amid ongoing nursing shortages CLINICALTRIAL Not applicable
- Open Access
- 15 April 2026
- Published by JMIR Publications Inc. in JMIR AI
Challenges and Opportunities for AI Tools in Healthcare: A Systematic Review from a Quadruple Aim Perspective. (Preprint)
- 15 April 2026
- Published by JMIR Publications Inc. in JMIR AI
Open AccessChallenges and Opportunities for AI Tools in Healthcare: A Systematic Review from a Quadruple Aim Perspective. (Preprint)
- Open Access
- 15 April 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Challenges and Opportunities for AI Tools in Healthcare:A Systematic Review from a Quadruple Aim Perspective (Preprint)
BACKGROUND Artificial intelligence (AI) has become one of the most transformative forces in modern medicine, promising enhanced diagnostic accuracy, predictive analytics, and greater operational efficiency across clinical settings. However, despite remarkable technical progress, translating AI systems from pilot projects to sustainable clinical use has been inconsistent. Many implementations remain confined to prototypes or local trials, while evidence about long-term value and equity is fragmented. The Quadruple Aim, improving patient experience, population health, cost efficiency, and provider well-being, offers a comprehensive framework for assessing whether AI truly advances the mission of value-based care. OBJECTIVE This systematic review synthesizes evidence from 34 peer-reviewed publications (2019–2026) to identify key challenges and opportunities in implementing AI tools in healthcare and to interpret findings through the Quadruple Aim framework. METHODS In accordance with PRISMA 2020 guidelines, a systematic search was conducted across PubMed, Scopus, and Web of Science. The initial search yielded 652 records. After removing 277 duplicates, 375 unique studies were screened by title and abstract, of which 283 were excluded for failing to meet the inclusion criteria. Following full-text assessment, 34 studies met all inclusion criteria. Data were extracted using a structured framework and synthesized thematically. Findings were mapped onto the four dimensions of the Quadruple Aim. RESULTS Of the 34 included studies, the most prevalent implementation barriers were workflow disruption and usability challenges (74%), trust and explainability limitations (71%), data quality and interoperability failures (68%), clinician knowledge and training gaps (62%), and regulatory uncertainty (53%). Key opportunities included predictive analytics and early warning systems (56%), stakeholder engagement and co-design (53%), workflow optimization and automation (50%), and patient engagement and access (44%). Mapping findings to the Quadruple Aim revealed that 23 studies addressed provider well-being, 22 addressed cost and system efficiency, 21 addressed patient experience, and 20 addressed population health. CONCLUSIONS Evidence from 34 peer-reviewed publications underscores both optimism and caution regarding AI’s role in healthcare. While most studies confirm AI’s potential to enhance quality, safety, and efficiency, barriers related to governance, transparency, workforce readiness, and equitable design continue to impede scale-up. Sustainable success requires aligning AI strategies with the Quadruple Aim through robust data governance, inclusive co-design, investment in digital-health literacy, and rigorous economic evaluation.
- 15 April 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessChallenges and Opportunities for AI Tools in Healthcare:A Systematic Review from a Quadruple Aim Perspective (Preprint)
BACKGROUND Artificial intelligence (AI) has become one of the most transformative forces in modern medicine, promising enhanced diagnostic accuracy, predictive analytics, and greater operational efficiency across clinical settings. However, despite remarkable technical progress, translating AI systems from pilot projects to sustainable clinical use has been inconsistent. Many implementations remain confined to prototypes or local trials, while evidence about long-term value and equity is fragmented. The Quadruple Aim, improving patient experience, population health, cost efficiency, and provider well-being, offers a comprehensive framework for assessing whether AI truly advances the mission of value-based care. OBJECTIVE This systematic review synthesizes evidence from 34 peer-reviewed publications (2019–2026) to identify key challenges and opportunities in implementing AI tools in healthcare and to interpret findings through the Quadruple Aim framework. METHODS In accordance with PRISMA 2020 guidelines, a systematic search was conducted across PubMed, Scopus, and Web of Science. The initial search yielded 652 records. After removing 277 duplicates, 375 unique studies were screened by title and abstract, of which 283 were excluded for failing to meet the inclusion criteria. Following full-text assessment, 34 studies met all inclusion criteria. Data were extracted using a structured framework and synthesized thematically. Findings were mapped onto the four dimensions of the Quadruple Aim. RESULTS Of the 34 included studies, the most prevalent implementation barriers were workflow disruption and usability challenges (74%), trust and explainability limitations (71%), data quality and interoperability failures (68%), clinician knowledge and training gaps (62%), and regulatory uncertainty (53%). Key opportunities included predictive analytics and early warning systems (56%), stakeholder engagement and co-design (53%), workflow optimization and automation (50%), and patient engagement and access (44%). Mapping findings to the Quadruple Aim revealed that 23 studies addressed provider well-being, 22 addressed cost and system efficiency, 21 addressed patient experience, and 20 addressed population health. CONCLUSIONS Evidence from 34 peer-reviewed publications underscores both optimism and caution regarding AI’s role in healthcare. While most studies confirm AI’s potential to enhance quality, safety, and efficiency, barriers related to governance, transparency, workforce readiness, and equitable design continue to impede scale-up. Sustainable success requires aligning AI strategies with the Quadruple Aim through robust data governance, inclusive co-design, investment in digital-health literacy, and rigorous economic evaluation.
- 31 December 2025
- Published by SAGE Publications in Face
- Vol. 7 (1) , 195-198
Digital Simulacra: Transparency and Trust in AI-Generated Visual Representations in Plastic and Reconstructive Surgery of the Face
- 31 December 2025
- Published by SAGE Publications in Face
- Vol. 7 (1) , 195-198
Digital Simulacra: Transparency and Trust in AI-Generated Visual Representations in Plastic and Reconstructive Surgery of the Face
- Open Access
- 31 August 2021
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 6 (3) , e17431
Health Internet Technology for Chronic Conditions: Review of Diabetes Management Apps
Background: Mobile health (mHealth) smartphone apps have shown promise in the self-management of chronic disease. In today’s oversaturated health app market, selection criteria that consumers are employing to choose mHealth apps for disease self-management are of paramount importance. App quality is critical in monitoring disease controls but is often linked to consumer popularity rather than clinical recommendations of effectiveness in disease management. Management of key disease variances can be performed through these apps to increase patient engagement in disease self-management. This paper provides a comprehensive review of features found in mHealth apps frequently used in the self- management of diabetes. Objective: The purpose of this study was to review features of frequently used and high consumer-rated mHealth apps used in the self-management of diabetes. This study aimed to highlight key features of consumer-favored mHealth apps used in the self-management of diabetes. Methods: A 2-fold approach was adopted involving the Apple iOS store and the Google search engine. The primary search was conducted on the Apple iOS store using the term “diabetes apps” (device used: Apple iPad). The top 5 most frequently used mHealth apps were identified and rated by the number of consumer reviews, app ratings, and the presence of key diabetes management features, such as dietary blood glucose, A1C, insulin, physical activity, and prescription medication. A subsequent Google search was conducted using the search term “best Apple diabetes apps.” The top 3 search results—“Healthline,” “Everyday Health,” and “Diabetes Apps–American Diabetes Association”—were explored. Results: In total, 12 mHealth apps were reviewed due to their appearing across 4 evaluated sources. Only 1 health app—Glucose Buddy Diabetes Tracker—appeared as the most frequently used within the Apple iOS store and across the other 3 sources. The OneTouch Reveal app ranked first on the list in the iOS store with 39,000 consumer reviews and a rating of 4.7 out of 5.0 stars but only appeared in 1 of the other 3 sources. Blood glucose tracking was present across all apps, but other disease management features varied in type with at least 3 of the 5 key features being present across the 12 reviewed apps. Subscription cost and integration needs were present in the apps which could impact consumers’ decision to select apps. Although mobile app preference was assessed and defined by the number of consumer reviews and star ratings, there were no scientific standards used in the selection and ranking of the health apps within this study. Conclusions: mHealth apps have shown promise in chronic disease management, but a surge in development of these nonregulated health solutions points to a need for regulation, standardization, and quality control. A governing body of health IT professionals, clinicians, policymakers, payors, and patients could be beneficial in defining health app standards for effective chronic disease management. Variabilities in features, cost, and other aspects of management could be reduced by regulatory uniformity, which would increase patient engagement and improve disease outcomes.
- 31 August 2021
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 6 (3) , e17431
Open AccessHealth Internet Technology for Chronic Conditions: Review of Diabetes Management Apps
Background: Mobile health (mHealth) smartphone apps have shown promise in the self-management of chronic disease. In today’s oversaturated health app market, selection criteria that consumers are employing to choose mHealth apps for disease self-management are of paramount importance. App quality is critical in monitoring disease controls but is often linked to consumer popularity rather than clinical recommendations of effectiveness in disease management. Management of key disease variances can be performed through these apps to increase patient engagement in disease self-management. This paper provides a comprehensive review of features found in mHealth apps frequently used in the self- management of diabetes. Objective: The purpose of this study was to review features of frequently used and high consumer-rated mHealth apps used in the self-management of diabetes. This study aimed to highlight key features of consumer-favored mHealth apps used in the self-management of diabetes. Methods: A 2-fold approach was adopted involving the Apple iOS store and the Google search engine. The primary search was conducted on the Apple iOS store using the term “diabetes apps” (device used: Apple iPad). The top 5 most frequently used mHealth apps were identified and rated by the number of consumer reviews, app ratings, and the presence of key diabetes management features, such as dietary blood glucose, A1C, insulin, physical activity, and prescription medication. A subsequent Google search was conducted using the search term “best Apple diabetes apps.” The top 3 search results—“Healthline,” “Everyday Health,” and “Diabetes Apps–American Diabetes Association”—were explored. Results: In total, 12 mHealth apps were reviewed due to their appearing across 4 evaluated sources. Only 1 health app—Glucose Buddy Diabetes Tracker—appeared as the most frequently used within the Apple iOS store and across the other 3 sources. The OneTouch Reveal app ranked first on the list in the iOS store with 39,000 consumer reviews and a rating of 4.7 out of 5.0 stars but only appeared in 1 of the other 3 sources. Blood glucose tracking was present across all apps, but other disease management features varied in type with at least 3 of the 5 key features being present across the 12 reviewed apps. Subscription cost and integration needs were present in the apps which could impact consumers’ decision to select apps. Although mobile app preference was assessed and defined by the number of consumer reviews and star ratings, there were no scientific standards used in the selection and ranking of the health apps within this study. Conclusions: mHealth apps have shown promise in chronic disease management, but a surge in development of these nonregulated health solutions points to a need for regulation, standardization, and quality control. A governing body of health IT professionals, clinicians, policymakers, payors, and patients could be beneficial in defining health app standards for effective chronic disease management. Variabilities in features, cost, and other aspects of management could be reduced by regulatory uniformity, which would increase patient engagement and improve disease outcomes.
- Open Access
- 2 February 2021
- Published by Partners in Digital Health in Telehealth and Medicine Today
Telehealth for Limiting Readmission Rates of COPD Patients: An Assessment Based on Medicare Data
Objective: Telemedicine has developed as an innovative way to remotely view and treat patients without necessitating for patients to physically come into a physicians’ office or healthcare facility. This study aims to provide insights into the effectiveness of integrating telemedicine in medical facilities, where patients have high hierarchical condition category (HCC) risk scores. Design: This study utilized two raw datasets: (1) a Centers for Medicare & Medicaid Services (CMS) dataset created from the 2017 Medicare Physician and Other Supplier National Provider Identity Aggregate Report and (2) a National Center for Education Statistics (NCES) dataset created from the NCES table on the number and percentage of households in each state with computer and internet access. A regression analysis was carried out on the CMS dataset to determine the correlation between HCC risk scores and the reimbursement lost by healthcare facilities, where over 50% of their patients are diagnosed with chronic obstructive pulmonary disease (COPD). A second analysis was conducted with the NCES dataset to show which states had a high proportion of both households with internet access and COPD patients. A final regression analysis was run and translated into an interactive map in order to determine which regions of the United States could most benefit from telemedicine adoption. Results: This study discovered a number of physicians and healthcare facilities in the eastern region of the United States that could benefit significantly from telemedicine applications. These findings were supported by the locations and data abstracted from facilities with high numbers of COPD patients, which were found to have poor HCC risk scores and thus high reimbursement losses. Conclusions: This study confirmed the association between HCC risk scores and reimbursement losses. In order to alleviate those losses, this study identified states across the United States that should choose to incorporate telemedicine into how they diagnose and treat patients based on the needs of healthcare facilities and the internet capabilities of households in those states, because telemedicine integration presents the potential to improve patient HCC risk scores and reimbursement amounts by lowering readmission rates while also promoting higher patient and physician satisfaction. Future efforts should develop specific strategies to assist with telemedicine implementation and should track the observed effects of its adoption on reimbursements and quality of care.
- 2 February 2021
- Published by Partners in Digital Health in Telehealth and Medicine Today
Open AccessTelehealth for Limiting Readmission Rates of COPD Patients: An Assessment Based on Medicare Data
Objective: Telemedicine has developed as an innovative way to remotely view and treat patients without necessitating for patients to physically come into a physicians’ office or healthcare facility. This study aims to provide insights into the effectiveness of integrating telemedicine in medical facilities, where patients have high hierarchical condition category (HCC) risk scores. Design: This study utilized two raw datasets: (1) a Centers for Medicare & Medicaid Services (CMS) dataset created from the 2017 Medicare Physician and Other Supplier National Provider Identity Aggregate Report and (2) a National Center for Education Statistics (NCES) dataset created from the NCES table on the number and percentage of households in each state with computer and internet access. A regression analysis was carried out on the CMS dataset to determine the correlation between HCC risk scores and the reimbursement lost by healthcare facilities, where over 50% of their patients are diagnosed with chronic obstructive pulmonary disease (COPD). A second analysis was conducted with the NCES dataset to show which states had a high proportion of both households with internet access and COPD patients. A final regression analysis was run and translated into an interactive map in order to determine which regions of the United States could most benefit from telemedicine adoption. Results: This study discovered a number of physicians and healthcare facilities in the eastern region of the United States that could benefit significantly from telemedicine applications. These findings were supported by the locations and data abstracted from facilities with high numbers of COPD patients, which were found to have poor HCC risk scores and thus high reimbursement losses. Conclusions: This study confirmed the association between HCC risk scores and reimbursement losses. In order to alleviate those losses, this study identified states across the United States that should choose to incorporate telemedicine into how they diagnose and treat patients based on the needs of healthcare facilities and the internet capabilities of households in those states, because telemedicine integration presents the potential to improve patient HCC risk scores and reimbursement amounts by lowering readmission rates while also promoting higher patient and physician satisfaction. Future efforts should develop specific strategies to assist with telemedicine implementation and should track the observed effects of its adoption on reimbursements and quality of care.
- Open Access
- 11 December 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Health Internet Technology for Chronic Conditions: Review of Diabetes Management Apps (Preprint)
BACKGROUND Mobile health (mHealth) smartphone apps have shown promise in the self-management of chronic disease. In today’s oversaturated health app market, selection criteria that consumers are employing to choose mHealth apps for disease self-management are of paramount importance. App quality is critical in monitoring disease controls but is often linked to consumer popularity rather than clinical recommendations of effectiveness in disease management. Management of key disease variances can be performed through these apps to increase patient engagement in disease self-management. This paper provides a comprehensive review of features found in mHealth apps frequently used in the self- management of diabetes. OBJECTIVE The purpose of this study was to review features of frequently used and high consumer-rated mHealth apps used in the self-management of diabetes. This study aimed to highlight key features of consumer-favored mHealth apps used in the self-management of diabetes. METHODS A 2-fold approach was adopted involving the Apple iOS store and the Google search engine. The primary search was conducted on the Apple iOS store using the term “diabetes apps” (device used: Apple iPad). The top 5 most frequently used mHealth apps were identified and rated by the number of consumer reviews, app ratings, and the presence of key diabetes management features, such as dietary blood glucose, A1C, insulin, physical activity, and prescription medication. A subsequent Google search was conducted using the search term “best Apple diabetes apps.” The top 3 search results—“Healthline,” “Everyday Health,” and “Diabetes Apps–American Diabetes Association”—were explored. RESULTS In total, 12 mHealth apps were reviewed due to their appearing across 4 evaluated sources. Only 1 health app—Glucose Buddy Diabetes Tracker—appeared as the most frequently used within the Apple iOS store and across the other 3 sources. The OneTouch Reveal app ranked first on the list in the iOS store with 39,000 consumer reviews and a rating of 4.7 out of 5.0 stars but only appeared in 1 of the other 3 sources. Blood glucose tracking was present across all apps, but other disease management features varied in type with at least 3 of the 5 key features being present across the 12 reviewed apps. Subscription cost and integration needs were present in the apps which could impact consumers’ decision to select apps. Although mobile app preference was assessed and defined by the number of consumer reviews and star ratings, there were no scientific standards used in the selection and ranking of the health apps within this study. CONCLUSIONS mHealth apps have shown promise in chronic disease management, but a surge in development of these nonregulated health solutions points to a need for regulation, standardization, and quality control. A governing body of health IT professionals, clinicians, policymakers, payors, and patients could be beneficial in defining health app standards for effective chronic disease management. Variabilities in features, cost, and other aspects of management could be reduced by regulatory uniformity, which would increase patient engagement and improve disease outcomes.
- 11 December 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessHealth Internet Technology for Chronic Conditions: Review of Diabetes Management Apps (Preprint)
BACKGROUND Mobile health (mHealth) smartphone apps have shown promise in the self-management of chronic disease. In today’s oversaturated health app market, selection criteria that consumers are employing to choose mHealth apps for disease self-management are of paramount importance. App quality is critical in monitoring disease controls but is often linked to consumer popularity rather than clinical recommendations of effectiveness in disease management. Management of key disease variances can be performed through these apps to increase patient engagement in disease self-management. This paper provides a comprehensive review of features found in mHealth apps frequently used in the self- management of diabetes. OBJECTIVE The purpose of this study was to review features of frequently used and high consumer-rated mHealth apps used in the self-management of diabetes. This study aimed to highlight key features of consumer-favored mHealth apps used in the self-management of diabetes. METHODS A 2-fold approach was adopted involving the Apple iOS store and the Google search engine. The primary search was conducted on the Apple iOS store using the term “diabetes apps” (device used: Apple iPad). The top 5 most frequently used mHealth apps were identified and rated by the number of consumer reviews, app ratings, and the presence of key diabetes management features, such as dietary blood glucose, A1C, insulin, physical activity, and prescription medication. A subsequent Google search was conducted using the search term “best Apple diabetes apps.” The top 3 search results—“Healthline,” “Everyday Health,” and “Diabetes Apps–American Diabetes Association”—were explored. RESULTS In total, 12 mHealth apps were reviewed due to their appearing across 4 evaluated sources. Only 1 health app—Glucose Buddy Diabetes Tracker—appeared as the most frequently used within the Apple iOS store and across the other 3 sources. The OneTouch Reveal app ranked first on the list in the iOS store with 39,000 consumer reviews and a rating of 4.7 out of 5.0 stars but only appeared in 1 of the other 3 sources. Blood glucose tracking was present across all apps, but other disease management features varied in type with at least 3 of the 5 key features being present across the 12 reviewed apps. Subscription cost and integration needs were present in the apps which could impact consumers’ decision to select apps. Although mobile app preference was assessed and defined by the number of consumer reviews and star ratings, there were no scientific standards used in the selection and ranking of the health apps within this study. CONCLUSIONS mHealth apps have shown promise in chronic disease management, but a surge in development of these nonregulated health solutions points to a need for regulation, standardization, and quality control. A governing body of health IT professionals, clinicians, policymakers, payors, and patients could be beneficial in defining health app standards for effective chronic disease management. Variabilities in features, cost, and other aspects of management could be reduced by regulatory uniformity, which would increase patient engagement and improve disease outcomes.